Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Rheumatology International|September 14, 2022
Colchicine and macrolides: a cohort study of the risk of adverse outcomes associated with concomitant exposureMalinda S Tan, Ainhoa Gomez-Lumbreras, Lorenzo Villa-Zapata, et al.Journal of Cardiovascular Pharmacology|September 9, 2022
Risk of Bleeding Among Individuals on Direct-Acting Oral Anticoagulants: An Academic Medical Center Cohort StudyAinhoa Gomez Lumbreras, Malinda S Tan, Krystal Moorman-Bishir, et al.Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 23, 2023
Cost-effectiveness analysis of five anti-obesity medications from a US payer's perspectiveAinhoa Gómez Lumbreras, Malinda S Tan, Lorenzo Villa-Zapata, et al.Drug Safety|July 14, 2022
A Disproportionality Analysis of Drug-Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS)Lorenzo Villa-Zapata, Ainhoa Gómez-Lumbreras, John Horn, et al.The Annals of Pharmacotherapy|January 23, 2023
Drugs That Interact With Colchicine Via Inhibition of Cytochrome P450 3A4 and P-Glycoprotein: A Signal Detection Analysis Using a Database of Spontaneously Reported Adverse Events (FAERS)Ainhoa Gómez-Lumbreras, Richard D Boyce, Lorenzo Villa-Zapata, et al.Journal of Electrocardiology|December 17, 2022
Relationship between a risk score for QT interval prolongation and mortality across rural and urban inpatient facilitiesMalinda S Tan, C William Heise, Tyler Gallo, et al.Journal of the American Heart Association|June 3, 2022
Clinician Responses to a Clinical Decision Support Advisory for High Risk of Torsades de PointesTyler Gallo, C William Heise, Raymond L Woosley, et al.Frontiers in Cardiovascular Medicine|July 7, 2023
A machine learning evaluation of patient characteristics associated with prescribing of guideline-directed medical therapy for heart failureRachel Kim, Krithika Suresh, Michael A Rosenberg, et al.Drug Safety|December 15, 2022
Colchicine Drug Interaction Errors and Misunderstandings: Recommendations for Improved Evidence-Based ManagementPhilip D Hansten, Malinda S Tan, John R Horn, et al.BMC Cancer|January 9, 2023
Cancer incidence in immunocompromised patients: a single-center cohort studySabrina Ilham, Connor Willis, Kibum Kim, et al.Pageof 2